Inventor
MJALLI ADNAN M M
US85 patents
⚠️ This page may combine multiple inventors who share the name “MJALLI ADNAN M M”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TRANSTECH PHARMA INC
19 patentsUS7329684B2Feb 12, 2008
Benzimidazole derivatives as therapeutic agents
TRANSTECH PHARMA INC91 citations98
US7812043B2Oct 12, 2010
N-heteroaryl indole carboxamides and analogues thereof, for use as glucokinase activators in the treatment of diabetes
TRANSTECH PHARMA INC93 citations97
US7501538B2Mar 10, 2009
Aryl and heteroaryl compounds, compositions and methods of use
TRANSTECH PHARMA INC107 citations97
US7459472B2Dec 2, 2008
Aryl and heteroaryl compounds, compositions, and methods of use
TRANSTECH PHARMA INC92 citations97
US7361678B2Apr 22, 2008
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
TRANSTECH PHARMA INC113 citations97
US7906507B2Mar 15, 2011
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA INC12 citations92
US7727983B2Jun 1, 2010
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA INC11 citations92
US7087632B2Aug 8, 2006
Benzimidazole derivatives as therapeutic agents
TRANSTECH PHARMA INC22 citations92
US7981424B2Jul 19, 2011
RAGE fusion proteins, formulations, and methods of use thereof
TRANSTECH PHARMA INC15 citations91
US7820821B2Oct 26, 2010
Benzazole derivatives, compositions, and methods of use as aurora kinase inhibitors
TRANSTECH PHARMA INC25 citations91
US7737285B2Jun 15, 2010
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
TRANSTECH PHARMA INC15 citations91
US7714013B2May 11, 2010
Azole derivatives and fused bicyclic azole derivatives as therapeutic agents
TRANSTECH PHARMA INC18 citations91
US6613801B2Sep 2, 2003
Method for the synthesis of compounds of formula I and their uses thereof
TRANSTECH PHARMA INC38 citations91
US7544699B2Jun 9, 2009
Aryl and heteroaryl compounds, compositions, and methods of use
TRANSTECH PHARMA INC22 citations90
US7423177B2Sep 9, 2008
Carboxamide derivatives as therapeutic agents
TRANSTECH PHARMA INC19 citations89
US7067554B2Jun 27, 2006
Method for the synthesis of compounds of formula I and their uses thereof
TRANSTECH PHARMA INC23 citations88
US7901688B2Mar 8, 2011
Rage fusion proteins
TRANSTECH PHARMA INC7 citations83
US7790714B2Sep 7, 2010
Oxadiazoanthracene compounds for the treatment of diabetes
TRANSTECH PHARMA INC10 citations83
US7723369B2May 25, 2010
Substituted imidazole derivatives, compositions, and methods of use as PTPase inhibitors
TRANSTECH PHARMA INC8 citations80
VTV THERAPEUTICS LLC
11 patentsUS10287284B2May 14, 2019
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC14 citations93
US10363244B2Jul 30, 2019
Compositions comprising metformin and a glucokinase activator
VTV THERAPEUTICS LLC5 citations84
US10064846B2Sep 4, 2018
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
VTV THERAPEUTICS LLC6 citations84
US9855251B2Jan 2, 2018
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
VTV THERAPEUTICS LLC7 citations84
US9393245B2Jul 19, 2016
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC7 citations84
US10568888B2Feb 25, 2020
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC2 citations73
US10391097B2Aug 27, 2019
Tricyclic compounds as modulators of TNF-alpha synthesis and as PDE4 inhibitors
VTV THERAPEUTICS LLC2 citations73
US11649230B2May 16, 2023
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC1 citations72
US11130753B2Sep 28, 2021
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC2 citations72
US10889580B2Jan 12, 2021
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC2 citations72
US10570126B2Feb 25, 2020
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
VTV THERAPEUTICS LLC2 citations72
MJALLI ADNAN M M
7 patentsUS7208601B2Apr 24, 2007
Aryl and heteroaryl compounds, compositions, and methods of use
MJALLI ADNAN M M121 citations95
US9359313B2Jun 7, 2016
Use of metformin in combination with a glucokinase activator and compositions comprising metformin and a glucokinase activator
MJALLI ADNAN M M16 citations92
US8759535B2Jun 24, 2014
Substituted fused imidazole derivatives, pharmaceutical compositions, and methods of use thereof
MJALLI ADNAN M M15 citations92
US8329715B2Dec 11, 2012
Tricyclic compounds as modulators of TNF-α synthesis and as PDE4 inhibitors
MJALLI ADNAN M M10 citations92
US8524708B2Sep 3, 2013
Oxadiazoanthracene compounds for the treatment of diabetes
MJALLI ADNAN M M6 citations83
US8877192B2Nov 4, 2014
Rage fusion proteins and methods of use
MJALLI ADNAN M M5 citations82
US8598353B2Dec 3, 2013
Benzazole derivatives, compositions, and methods of use as β-secretase inhibitors
MJALLI ADNAN M M6 citations82
NOVO NORDISK AS
5 patentsUS7384967B2Jun 10, 2008
Aryl carbonyl derivatives as therapeutic agents
NOVO NORDISK AS166 citations98
USRE45670ESep 15, 2015
Aryl carbonyl derivatives as therapeutic agents
NOVO NORDISK AS34 citations97
US7541373B2Jun 2, 2009
Aryl carbonyl derivatives as therapeutic agents
NOVO NORDISK AS123 citations97
US7897628B2Mar 1, 2011
Aryl carbonyl derivatives as therapeutic agents
NOVO NORDISK AS15 citations91
US6169087B1Jan 2, 2001
Modulators of protein tyrosine phosphatases (PTPases)
NOVO NORDISK AS16 citations83
ONTOGEN CORP
3 patentsUS5770620AJun 23, 1998
Aryl acrylic acid derivatives useful as protein tyrosine phosphatase inhibitors
ONTOGEN CORP56 citations93
US5840721ANov 24, 1998
Imidazole derivatives as MDR modulators
ONTOGEN CORP26 citations92
US5756527AMay 26, 1998
Imidazole derivatives useful as modulators of multi drug resistances
ONTOGEN CORP23 citations92
TRANSTECH PHARMA LLC
2 patents(unassigned)
1 patentADVANCED SYNTECH LLC
1 patentTRANSTECH PHARM INC
1 patentShowing the top 50 of 85 patents by PatentIndex Score.